XML 56 R45.htm IDEA: XBRL DOCUMENT v3.20.2
ACQUISITIONS - Purchase Price Allocation (Details) - USD ($)
$ in Thousands
3 Months Ended 4 Months Ended
May 20, 2020
Sep. 30, 2020
Sep. 30, 2020
Jun. 30, 2020
Dec. 31, 2019
Jan. 31, 2019
Purchase Price Allocation to Fair Value            
Goodwill   $ 9,008 $ 9,008   $ 0  
13% Senior Secured Note due 2024 | Senior Notes            
Adjustments to Purchase Price Allocation to Fair Value            
Interest rate 13.00% 13.00% 13.00%      
13% Senior Secured Note due 2024 | Senior Notes | Zyla Life Sciences            
Adjustments to Purchase Price Allocation to Fair Value            
Interest rate           13.00%
Zyla Life Sciences            
Purchase Price Allocation to Fair Value            
Cash $ 7,585 $ 7,585 $ 7,585      
Accounts receivable 23,133 23,133 23,133      
Inventories 26,742 14,261 14,261      
Property and equipment 4,512 1,496 1,496      
Intangible assets 160,900 193,400 193,400      
Other assets 9,629 7,665 7,665      
Total identifiable assets acquired 232,501 247,540 247,540      
Accounts payable 21,574 21,574 21,574      
Accrued rebates, returns and discounts 33,254 33,254 33,254      
Other accrued liabilities 15,434 15,434 15,434      
Contingent consideration 29,400 39,900 39,900      
Debt 111,900 111,300 111,300      
Total liabilities assumed 211,562 221,462 221,462      
Net identifiable assets acquired 20,939 26,078 26,078      
Goodwill 14,147 9,008 9,008 $ 9,000    
Net assets acquired 35,086 35,086 35,086      
Adjustments to Purchase Price Allocation to Fair Value            
Inventories     (12,481)      
Property and equipment     (3,016)      
Intangible assets     32,500      
Other assets     (1,964)      
Total identifiable assets acquired     15,039      
Other accrued liabilities     0      
Contingent consideration     10,500      
Debt     (600)      
Total liabilities assumed     9,900      
Net identifiable assets acquired     5,139      
Goodwill   (5,100) (5,139)      
Zyla Life Sciences | Promissory note            
Purchase Price Allocation to Fair Value            
Debt   3,000 3,000      
Adjustments to Purchase Price Allocation to Fair Value            
Repayment of debt 3,000          
Zyla Life Sciences | Credit agreement            
Purchase Price Allocation to Fair Value            
Debt   10,000 10,000      
Adjustments to Purchase Price Allocation to Fair Value            
Repayment of debt $ 10,000          
Zyla Life Sciences | 13% Senior Secured Note due 2024 | Senior Notes            
Purchase Price Allocation to Fair Value            
Debt   95,000 95,000      
Zyla Life Sciences | Royalty rights obligation | Senior Notes            
Purchase Price Allocation to Fair Value            
Debt   $ 3,300 $ 3,300